« All Events
Outcomes for High-Risk MDS Patients Undergoing Transplant vs Standard Non-Transplant Therapies Webinar
August 7, 2021 @ 12:00 pm - 1:30 pm
- August 7, 2021: Outcomes for High-Risk MDS Patients Undergoing Transplant vs Standard Non-Transplant Therapies @12 pm ET
Erica D. Warlick, MD, University of Minnesota Medical Center
This webinar will provide an overview of the role of allogeneic hematopoietic cell transplantation (alloHCT) for high-risk MDS patients. Standard therapies for patients with MDS including hypomethylating agents (HMAs) and a variety of novel agents outside of allogeneic HCT will be discussed.
Register Now
